These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26775802)

  • 21. Kounis Syndrome—not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease.
    Kounis NG; Koniari I; Velissaris D; Tzanis G; Hahalis G
    Balkan Med J; 2019 Jul; 36(4):212-221. PubMed ID: 31198019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.
    Molderings GJ; Brettner S; Homann J; Afrin LB
    J Hematol Oncol; 2011 Mar; 4():10. PubMed ID: 21418662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.
    Jackson CW; Pratt CM; Rupprecht CP; Pattanaik D; Krishnaswamy G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and Pathology of Mastocytosis.
    Metcalfe DD; Mekori YA
    Annu Rev Pathol; 2017 Jan; 12():487-514. PubMed ID: 28135563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M; Giavina-Bianchi P; Mezzano V; Castells M
    Clin Ther; 2013 May; 35(5):548-62. PubMed ID: 23642289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.
    Valent P; Horny HP; Triggiani M; Arock M
    Int Arch Allergy Immunol; 2011; 156(2):119-27. PubMed ID: 21576982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mast cell activation disease and the modern epidemic of chronic inflammatory disease.
    Afrin LB
    Transl Res; 2016 Aug; 174():33-59. PubMed ID: 26850903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Right cardiac insufficiency disclosing systemic mastocytosis].
    Morvan Y; Collet E; Bielefeld P; Meyer P; Chantereau MJ; Baudet JG; Dalac S; Besancenot JF
    Rev Med Interne; 1992; 13(5):367-70. PubMed ID: 1344833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastocytosis in Children.
    Klaiber N; Kumar S; Irani AM
    Curr Allergy Asthma Rep; 2017 Oct; 17(11):80. PubMed ID: 28988349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mastocytosis: oral implications of a rare disease.
    Rama TA; Côrte-Real I; Gomes PS; Escribano L; Fernandes MH
    J Oral Pathol Med; 2011 Jul; 40(6):441-50. PubMed ID: 21198873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stinging Hymenoptera and mastocytosis.
    Ruëff F; Dugas-Breit S; Przybilla B
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):338-42. PubMed ID: 19474708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylaxis as a clinical manifestation of clonal mast cell disorders.
    Matito A; Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L
    Curr Allergy Asthma Rep; 2014 Aug; 14(8):450. PubMed ID: 24947681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.
    Alvarez-Twose I; Zanotti R; González-de-Olano D; Bonadonna P; Vega A; Matito A; Sánchez-Muñoz L; Morgado JM; Perbellini O; García-Montero A; De Matteis G; Teodósio C; Rossini M; Jara-Acevedo M; Schena D; Mayado A; Zamò A; Mollejo M; Sánchez-López P; Cabañes N; Orfao A; Escribano L; ;
    J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow-mediated dilation shows impaired endothelial function in patients with mastocytosis.
    Bucci T; Parente R; De Feo G; Cardamone C; Triggiani M
    J Allergy Clin Immunol; 2019 Oct; 144(4):1106-1111. PubMed ID: 31211959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-allergic, mastocytosis-associated rhinitis.
    Dollner R; Taraldsrud E; Iversen K; Osnes T; Kristensen B; Kramer MF
    Clin Exp Allergy; 2013 Apr; 43(4):406-12. PubMed ID: 23517036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mastocytosis, classification, biological diagnosis and therapy].
    Arock M
    Ann Biol Clin (Paris); 2004; 62(6):657-69. PubMed ID: 15563424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.